HOLLY SMITH: Open Payments
NPI 1023598588 · PORT ORANGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 19 payments from 7 companies in 2025. Trend: 2023 $304 · 2024 $769 · 2025 $460
Food & beverage: $376Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $170 |
| Madrigal Pharmaceuticals | 3 | $65 |
| Celltrion USA Inc. | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 1 | $47 |
| GENZYME CORPORATION | 2 | $46 |
| Medtronic, Inc. | 1 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
Products named: TREMFYA, REZDIFFRA, VEGZELMA, VOQUEZNA, DUPIXENT, INTERSTIM, XIFAXAN.
Industry payments across FL — which companies pay providers there.
